Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride reduces prostate cancer risk but may affect ejaculatory volume and requires careful consideration for young men.

Finasteride improves prostate cancer detection in PSA test.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Systematic end-of-trial biopsies are the most reliable way to assess outcomes.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Finasteride reduces prostate size, improves urination, and slows prostate cancer progression.

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

5ARIs lower PSA levels, but other tests are needed to avoid missing aggressive prostate cancer.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

Finasteride can reduce prostate cancer risk but may delay diagnosis and cause sexual side effects.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Finasteride caused long-term sexual and non-sexual side effects in young men with hair loss.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Testosterone replacement therapy should be used for men with low testosterone levels and symptoms of hypogonadism, after careful diagnosis and considering individual needs.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Early hair loss may indicate future prostate issues.